PHAXIAM Therapeutics S.A. Sponsored ADR EBITDA 2020-2023 | PHXM

PHAXIAM Therapeutics S.A. Sponsored ADR ebitda from 2020 to 2023. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
PHAXIAM Therapeutics S.A. Sponsored ADR Annual EBITDA
(Millions of US $)
2022 $2
2021 $-61
2020 $-73
2019 $-73
2018 $-56
2017 $-38
2016 $-29
PHAXIAM Therapeutics S.A. Sponsored ADR Quarterly EBITDA
(Millions of US $)
2019-09-30 $-18